Cerca
Close this search box.

Bifidobacterium breve – M-16V

Tabella dei contenuti

Clinical indications

immune stimulation, Allergy

Area of use

Immunity strain I Cow Milk Protein Allergy

Characteristics

DAILY DOSAGE IN CLINICAL STUDY
1.4 billion CFU per 100 mL serving

FUNCTIONALITY
CMPA – Cow Milk Protein Allergy (including Colic due to CMPA) [Children use]

Scientific support

Human clinical trial

Burks AW, Harthoorn LF, et al. “Synbiotics-supplemented amino acid-based formula supports adequate growth in cow’s milk allergic infants.” Pediatr Allergy Immunol. 2015;26(4):316-22

Harvey BM, Langford JE, et al. “Effects on growth and tolerance and hypoallergenicity of an amino acid-based formula with synbiotics.” Pediatr Res. 2014;75(2):343-51

Candy D, Van Ampting M et al. “A synbiotic-containing amino-acid-based formula improves gut microbiota in non-IgE-mediated allergic infants.” Pediatr Res. 2018 Mar;83(3):677-686

Wopereis H., van Ampting M. et al. “A specific synbiotic-containing amino acid-based formula restores gut microbiota in non-IgE mediated cow’s milk allergic infants: a randomized controlled trial” Clin Transl Allergy (2019) 9:27

Fox A, Woperies H et al. “A specific synbiotic-containing amino acid-based formula in dietary management of cow’s milk allergy: a randomized controlled trial” Clin Transl Allergy (2019) 9:5

Oppure effettua il login